IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q4 2016 Holdings

Filed 2017-02-14 | 18 holdings | $2.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cellectis(CLLS)SPONDS ADR15117K103$1.7M100,00060.2%
Adaptimmune(ADAPY)SPONDS ADR00653A107$1.0M250,00035.7%
Crispr(CRSP)CommonH17182108$52.0K2,601,8141.9%
ParatekCommon699374302$20.0K1,301,4130.7%
SientraCommon82621J105$18.7K2,199,0120.7%
NovanCommon66988N106$5.4K200,0000.2%
Chiasma(CHMA)Common16706W102$4.0K2,080,5950.1%
ProteonCommon74371L109$3.6K2,017,8720.1%
Cymabay(CBAYUSD)Common23257D103$2.7K1,600,0000.1%
Dermira(DERMEUR)Common24983L104$2.1K70,0000.1%
Lombard MedicalCommonG55598109$2.0K3,473,4520.1%
HistogenixCommon43358V109$1.4K888,8890.1%
Senseonics(SENS1GBP)Common81727U105$1.4K516,8820.0%
AntheraCommon03674U201$1.2K861,7230.0%
Immune DesignCommon45252L103$1.1K197,3000.0%
Dicerna(DRNAUSD)Common253031108$973337,8250.0%
InnocollSPONDS ADR45780Q103$360537,2350.0%